WithdrawnNot Applicable

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients

Stopped: The study will not be conducted

0Started 2023-06-10

Plain-language summary

Vifor International Ltd. is seeking real-world evidence (RWE) to better understand the epidemiology, patient characteristics, and management of CKD-aP in the real-world clinical setting.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female adult patients with CKD (≥18 years) receiving HD for at least 3 months prior to signing informed consent * Signed informed consent * Able and willing to fill in questionnaires Exclusion Criteria: * Patients receiving HD at home or both home and site

What they're measuring

Prevalence (%) of CKD-aP patients undergoing HD based on the WI-NRS score (past 24 hours).

Timeframe: Day 1

Trial details

NCT IDNCT05625542

SponsorVifor (International) Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-06-10

View on ClinicalTrials.gov More Chronic Kidney Disease-associated Pruritus trials